org placeholder image

Nick Bourbeau

Ta Specialist at REGENXBIO

  • LinkedIn

Email Email: n****@regenxbio.com

phone noPhone Number: (***)-***-****

map
REGENXBIO

REGENXBIO

  • description Description
    REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adenoassociated virus (AAV) gene therapy. REGENXBIO's NAV Technology Pl...

    Read More

  • Employees count Employees 201-500
  • Revenue Revenue 250 Million to 500 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

REGENXBIO Org Chart and Mapping

Lisa Reid

Executive Assistant to Chief Executive Officer

Employees

Michele Fiscella

Vice President, Preclinical Development and Bioanalytical Sciences

Mansi Shah

Automation Engineer II

Patrick Omalley

Senior Director, Controller

Nga Hilvano

Clinical Research Associate I

Brianne Spencer

Clinical Project Manager

Ethan Vernon

Clinical Supply Intern

Barbara Duke

Clinical Systems Associate

Lydia Joyner

Target Discovery Research Intern

Frequently Asked Questions Regarding Nick Bourbeau

Answer: Nick Bourbeau works for REGENXBIO as Ta Specialist

Answer: Nick Bourbeau’s role in REGENXBIO is Ta Specialist

Answer: Nick Bourbeau's email address is n***@gmail.com

Answer: Nick Bourbeau's business email address is n****@regenxbio.com

Answer: Nick Bourbeau’s direct phone number is (***)-***-****

Answer: Nick Bourbeau works in the industry of: Biotechnology

Answer: Nick Bourbeau works REGENXBIO located at 9804 Medical Center Dr, Rockville, Maryland, 20850, United States

Answer: REGENXBIO's Ta Specialist is Nick Bourbeau

Answer: Nick Bourbeau contact details:

  • Phone number  :  (***)-***-****
  • Email  :  n****@regenxbio.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access